Back to Browse Journals » International Journal of Nanomedicine » Volume 1 » Issue 4

Megestrol acetate in cachexia and anorexia

Authors Shing-Shing Yeh, Michael W Schuster

Published Date February 2006 Volume 2006:1(4) Pages 411—416

DOI http://dx.doi.org/

Published 23 February 2006

Shing-Shing Yeh1, Michael W Schuster2

1Northport vAMC, Geriatric division, Northport, NY 11768; 2Weill Medical College of Cornell University and the New York Presbyterian Hospital, New York, NY 10021, USA

Abstract: The aim is to review major clinical trials that have used megestrol acetate (MA) in the treatment of cachexia across several disease states. A review of general usage and potential side-effects are discussed. A theory that the newly approved nanocrystal formation of MA can better deliver this potent medication for treatment will also be reviewed.

Keywords: megestrol acetate, nanocrystalline particles, cachexia

Download Article [PDF] 

Readers of this article also read:

Disease burden and patient reported outcomes among patients with moderate to severe psoriasis: an ethnography study

Narayanan S, Guyatt V, Franceschetti A, Hautamaki EL

Psoriasis: Targets and Therapy 2015, 5:1-7

Published Date: 23 December 2014

Lumbosacral plexus delineation, dose distribution, and its correlation with radiation-induced lumbosacral plexopathy in cervical cancer patients

Tunio M, Al Asiri M, Bayoumi Y, Abdullah O Balbaid A, AlHameed M, Gabriela SL, Amir O Ali A

OncoTargets and Therapy 2015, 8:21-27

Published Date: 23 December 2014

Formulation and evaluation of drug-loaded targeted magnetic microspheres for cancer therapy

Enriquez GG, Rizvi SAA, D’Souza MJ, Do DP

International Journal of Nanomedicine 2013, 8:1393-1402

Published Date: 10 April 2013

Development of a nanoporous and multilayer drug-delivery platform for medical implants

Karagkiozaki V, Vavoulidis E, Karagiannidis PG, Gioti M, Fatouros DG, Vizirianakis IS, Logothetidis S

International Journal of Nanomedicine 2012, 7:5327-5338

Published Date: 8 October 2012

Mood fluctuations in Parkinson’s disease: a pilot study comparing the effects of intravenous and oral levodopa administration

Irene Hegeman Richard, Samuel Frank, Kori A LaDonna, Hongkun Wang, Michael P McDermott, Roger Kurlan

Neuropsychiatric Disease and Treatment 2005, 1:261-268

Published Date: 18 February 2005